Medigen Competitors and Similar CompaniesClear all
Uvax Bio's competitors and similar companies include CellPly and HiberCell.
 Uvax Bio Uvax Bio is a spin-off vaccine company that employs patented single-component self-assembling protein nanoparticle platform technology. |  CellPly CellPly is a company developing in-vitro diagnostic platforms supporting personalized cancer treatment. |  HiberCell HiberCell is a company that focuses on therapeutically modulating the biology and mechanisms of tumor dormancy. | |
Founding Date | Founding Date 2018 | Founding Date 2013 | Founding Date 2019 |
Type | Type Private | Type Private | Type Private |
Tags | |||
Locations | Locations Wilmington, US HQ | Locations Bologna, IT HQ Bologna, IT | Locations New York, US HQ Roseville, US |
Employees | Employees 1110% increase | Employees 313% decrease | Employees 264% decrease |
Funding | |||
Latest funding round | Latest funding round N/A | Latest funding round $ 341.6k (over 7 years ago) | Latest funding round $ 67.4m (about 5 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised $ 5.9m | Total funding raised $ 128.2m |
For sources of this data, please see the company profile
View Company Profiles
CellPly
HQ
Bologna, IT
Employees
31↓ 3% decrease
CellPly is a company developing in-vitro diagnostic platforms supporting personalized cancer treatment.
View companyHiberCell
HQ
New York, US
Employees
26↓ 4% decrease
HiberCell is a company that focuses on therapeutically modulating the biology and mechanisms of tumor dormancy.
View company